The systemic scleroderma drug pipeline analysis focuses on innovative therapies targeting this rare autoimmune disease characterized by skin thickening and internal organ involvement. With limited treatment options currently available, the pipeline is advancing through research in immunomodulators, anti-fibrotic agents, and biologics to address the high unmet medical need and improve ... https://www.expertmarketresearch.com/clinical-trials/autism-drug-pipeline-insight